Largest pharmaceuticals by earnings

Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.

Johnson & Johnson leads the 61 pharmaceuticals ranked by earnings, at $26.8B, ahead of Eli Lilly ($20.6B) and Merck & Co ($18.3B). Figures as of 17 Nov 2026, 17:20 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
61
First
Johnson & Johnson$26.8B
Median
$59M
Combined market value
$5.17T
Countries
10

Market values as of .

Largest pharmaceuticals by earnings
#CompanyEarnings ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Johnson & JohnsonJNJ · Health Care$26.8B$675.4B$280.57 0.70% down 41% up United States
2Eli LillyLLY · Health Care$20.6B$1.26T$1,416.29 1.07% down 39% up United States
3Merck & CoMRK · Health Care$18.3B$354.9B$143.98 0.33% down 50% up United States
4Novo NordiskNVO · Health Care$15.2B$179.3B$40.69 2.18% down 13% down Denmark
5NovartisNVS · Health Care$14B$301.9B$159.86 0.21% down 25% up Switzerland
6AstraZenecaAZN · Health Care$10.2B$284.4B$183.39 0.34% down 3% up United Kingdom
7SanofiSNY · Health Care$8.7B$115.1B$47.93 0.96% down 4% down France
8PfizerPFE · Health Care$7.8B$162.7B$28.54 1.11% down 13% up United States
9GSKGSK · Health Care$7.6B$99.2B$49.49 1.83% down 6% up United Kingdom
10Bristol-Myers SquibbBMY · Health Care$7.1B$124.5B$60.93 3.19% down 34% up United States
11Abbott LaboratoriesABT · Health Care$6.5B$184B$106.24 1.13% down 17% down United States
12Regeneron PharmaceuticalsREGN · Health Care$4.5B$99.5B$961.54 0.96% up 31% up United States
13AbbVieABBV · Health Care$4.2B$518.2B$293.17 0.47% down 26% up United States
14Vertex PharmaceuticalsVRTX · Health Care$4B$135.5B$534.47 0.62% down 23% up United States
15ZoetisZTS · Health Care$2.7B$34.1B$83.85 0.64% down 29% down United States
16Teva Pharmaceutical IndustriesTEVA · Health Care$1.4B$49.2B$42.14 1.01% down 71% up Israel
17United TherapeuticsUTHR · Health Care$1.3B$24.7B$579.15 1.48% down 23% up United States
18GenmabGMAB · Health Care$963M$31.9B$51.80 0.45% up 70% up Denmark
19Royalty PharmaRPRX · Health Care$770.9M$39.3B$68.35 0.26% down 74% up United States
20PTC TherapeuticsPTCT · Health Care$682.6M$5B$60.05 1.51% down 20% down United States
21Dr. Reddy's LaboratoriesRDY · Health Care$456M$12.4B$14.89 1.29% up 5% up India
22TG TherapeuticsTGTX · Health Care$447.2M$9.5B$62.88 0.19% up 101% up United States
23GrifolsGRFS · Health Care$446M$5.9B$8.64 1.03% down 2% up Spain
24BioMarin PharmaceuticalBMRN · Health Care$348.9M$11.3B$58.39 0.69% up 7% up United States
25Alnylam PharmaceuticalsALNY · Health Care$313.7M$21.1B$157.19 1.59% down 65% down United States
26BeOne MedicinesONC · Health Care$286.9M$46.9B$410.40 0.22% down 13% up Switzerland
27AlkermesALKS · Health Care$241.7M$7.7B$45.54 2.13% down 59% up Ireland
28Ligand PharmaceuticalsLGND · Health Care$124.5M$6B$299.42 0.76% down 46% up United States
29Corcept TherapeuticsCORT · Health Care$99.7M$7.8B$71.13 2.75% up 8% down United States
30Amneal PharmaceuticalsAMRX · Health Care$72.1M$7.3B$21.08 0.71% down 83% up United States
31Kiniksa Pharmaceuticals InternationalKNSA · Health Care$59M$7.4B$94.56 0.35% up 128% up United Kingdom
32Arrowhead PharmaceuticalsARWR · Health Care-$1.6M$6.1B$43.45 1.73% down 9% up United States
33Mirum PharmaceuticalsMIRM · Health Care-$23.4M$5.9B$90.88 0.76% down 27% up United States
34Travere TherapeuticsTVTX · Health Care-$25.5M$4.8B$50.28 1.17% up 38% up United States
35VeradermicsMANE · Health Care-$70M$5.3B$126.39 1.30% down 239% up United States
36Belite BioBLTE · Health Care-$77.6M$6.3B$157.15 3.33% down 32% up United States
37Oruka TherapeuticsORKA · Health Care-$105.4M$6.6B$96.66 2.60% down 262% up United States
38ErascaERAS · Health Care-$124.5M$5.1B$14.57 3.57% down 428% up United States
39Protagonist TherapeuticsPTGX · Health Care-$130.1M$8.2B$125.30 0.38% up 48% up United States
40Spyre TherapeuticsSYRE · Health Care-$155.2M$9B$94.95 4.45% down 312% up United States
41Dianthus TherapeuticsDNTH · Health Care-$162.3M$4.9B$87.28 2.54% down 119% up United States
42Edgewise TherapeuticsEWTX · Health Care-$167.8M$4.6B$42.05 3.73% down 97% up United States
43Axsome TherapeuticsAXSM · Health Care-$183.2M$7.2B$136.72 0.21% down 7% down United States
44Definium TherapeuticsDFTX · Health Care-$183.8M$4B$29.36 2.64% down 164% up United States
45Rhythm PharmaceuticalsRYTM · Health Care-$196.5M$7.9B$113.72 5.80% up 7% up United States
46Elanco Animal HealthELAN · Health Care-$232M$13B$26.06 1.33% down 23% up United States
47Ascendis PharmaASND · Health Care-$253M$17.5B$267.14 1.69% down 25% up Denmark
48Madrigal PharmaceuticalsMDGL · Health Care-$288.3M$9.9B$426.93 0.70% up 24% down United States
49Legend BiotechLEGN · Health Care-$296.8M$3.2B$16.27 1.75% up 46% down United States
50Roivant SciencesROIV · Health Care-$299.8M$27.8B$38.43 0.47% down 88% up United Kingdom
51Praxis Precision MedicinesPRAX · Health Care-$303.3M$8.6B$308.39 0.61% down 69% up United States
52Cogent BiosciencesCOGT · Health Care-$328.9M$4.7B$26.98 1.68% down 18% down United States
53Jazz PharmaceuticalsJAZZ · Health Care-$356.1M$15.6B$242.34 1.07% up 33% up Ireland
54ABIVAXABVX · Health Care-$372.9M$7.3B$83.30 0.37% down 27% down France
55Ionis PharmaceuticalsIONS · Health Care-$381.4M$4.5B$27.05 3.43% down 62% down United States
56BridgeBio PharmaBBIO · Health Care-$732.9M$14.9B$76.63 0.94% down 18% up United States
57CytokineticsCYTK · Health Care-$785M$7.2B$51.87 2.44% down 20% down United States
58Takeda PharmaceuticalTAK · Health Care-$954.4M$69.4B$21.71 0.56% up 53% up Japan
59Summit TherapeuticsSMMT · Health Care-$1.1B$8.7B$10.94 7.49% down 30% down United States
60InsmedINSM · Health Care-$1.3B$26.3B$119.75 2.55% down 39% down United States
61ViatrisVTRS · Health Care-$3.5B$23.7B$20.63 0.53% down 94% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period.

Questions and answers

Which pharmaceuticals rank first by earnings?

Johnson & Johnson ($26.8B), Eli Lilly ($20.6B) and Merck & Co ($18.3B) are the top three of the 61 pharmaceuticals ranked by earnings as of 17 Nov 2026, 17:20 UTC.

How many pharmaceuticals are in this ranking?

61 are ranked by earnings.

What are these pharmaceuticals worth together?

Their combined market value is $5.17T as of 17 Nov 2026, 17:20 UTC.

What does ranking by earnings measure?

Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.

Cite this page

Funkfolio, “Largest pharmaceuticals by earnings”, data as of 17 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=earnings

Underlying data: Yahoo Finance; SEC EDGAR.